Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31409465 | 0.93 | ALDH1A1 (0.57) | ALDH1A1RAB9AHTTHSD17B10HPGD | |
| SCHEMBL29642680 | 0.89 | CYP3A4 (0.75) | ALDH1A1RAB9AHPGDCYP1A2CYP3A4 | |
| SCHEMBL3944098 | 0.89 | CYP3A4 (0.75) | ALDH1A1RAB9AHPGDCYP1A2CYP3A4 | |
| SCHEMBL138875 | 0.89 | CYP3A4 (0.75) | ALDH1A1RAB9AHPGDCYP1A2CYP3A4 | |
| SCHEMBL7332204 | 0.87 | CYP3A4 (0.73) | ALDH1A1RAB9AHPGDCYP1A2CYP3A4 | |
| Hydrochloric Acid SCHEMBL8838333 | 0.87 | CYP3A4 (0.73) | ALDH1A1RAB9AHPGDCYP1A2CYP3A4 | |
| SCHEMBL1468159 | 0.87 | ALDH1A1 (0.62) | ALDH1A1RAB9AHTTHSD17B10HPGD | |
| SCHEMBL3349791 | 0.86 | ALDH1A1 (0.81) | ALDH1A1RAB9AHTTHSD17B10HPGD | |
| SCHEMBL13957312 | 0.86 | ALDH1A1 (0.57) | ALDH1A1RAB9AHTTHSD17B10HPGD | |
| SCHEMBL5207755 | 0.84 | ALDH1A1 (0.59) | ALDH1A1RAB9AHTTHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5631038-A | COMPOUNDS (TASTANDS) TO REDUCE OR ELIMINATE A BITTER OR METALLIC TASTE ARE ADDED TO FOODS CONTAINING SODIUM CHLORIDE | BIORESEARCH, INC. (US) | 1997-05-20 | — | — | US | claimed |
| US-5631294-A | PHENOXY- OR PHENYL-ALKANOIC ACIDS | BIORESEARCH, INC. (US) | 1997-05-20 | — | — | US | claimed |
| EP-0727151-A2 | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers | BIORESEARCH, INC. (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0661932-A4 | SPECIFIC EATABLE TASTE MODIFIERS. | BIORESEARCH INC (US) | 1996-06-05 | — | — | EP | claimed |
| CN-1029932-C | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers | BIORESEARCH INC (US) | 1995-10-11 | — | — | CN | claimed |
| EP-0661932-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1995-07-12 | — | — | EP | claimed |
| WO-1993010677-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| CN-1060770-A | The sweetness inhibitor that contains substantially tasteless is as bitter inhibitor or contain the absorbed thing of the bitter inhibitor of substantially tasteless as sweetness inhibitor | BIORESEARCH INC (US) | 1992-05-06 | — | — | CN | claimed |
| WO-1991018523-A1 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS | BIORESEARCH, INC. (US) | 1991-12-12 | — | — | WO | claimed |
| EP-0125049-B1 | METHOD OF INHIBITING SWEETNESS | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-07-30 | — | — | EP | claimed |
| EP-0125049-A1 | Method of inhibiting sweetness | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1984-11-14 | — | — | EP | claimed |
| WO-2026104679-A1 | NOVEL SULFONAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-05-21 | — | — | WO | disclosed |
| EP-4734977-A2 | NOVEL TRPV1 AGONISTS AND USES THEREOF | Neucures, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260062399-A1 | SUBSTITUTED ETHYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVES | ENVERIC BIOSCIENCES CANADA INC (CA) | 2026-03-05 | — | — | US | disclosed |
| US-12492179-B2 | Substituted ethylamine fused heterocyclic mescaline derivatives | Enveric Biosciences Canada Inc. (CA) | 2025-12-09 | — | — | US | disclosed |
| EP-0125049-B1 | METHOD OF INHIBITING SWEETNESS | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-07-30 | — | — | EP | disclosed |
| US-4567053-A | Method of inhibiting sweetness | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-01-28 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| EP-0125049-A1 | Method of inhibiting sweetness | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1984-11-14 | — | — | EP | disclosed |
| US-4247597-A | Electroscopic carrier particles having a carboxylic acid surface treatment | PITNEY BOWES, INC. (US) | 1981-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492179-B2 | Substituted ethylamine fused heterocyclic mescaline derivatives | DRD2, HTR5A, SLC18A2 | ALDH1A1 402/4885RAB9A 798/4885HTT 1736/4885 |
| US-20260062399-A1 | SUBSTITUTED ETHYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVES | HTR1D, ADRA1D, CHRM1 | ALDH1A1 219/4885RAB9A 362/4885HTT 3170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.